Central nervous system (CNS) stimulation is the primary action of a diverse group of pharmacological
agents and an adverse effect associated with the administration of an even larger group of drugs. CNS
stimula tion consists of a range of behaviors including mild elevation in alertness, increased nervousness and anxiety,and convulsions.
In general, any hyperexcitability associated with drug administration (as either a desired or an undesired
effect) results from an alteration in the fine balance normally maintained in the CNS between excitatory and
inhibitory influences. Thus, the bases for CNS stimulation by this class of drugs reside in adjusting the inte-
gration of excitatory and inhibitory influences at the level of the individual neuron. An agent that induces
CNS stimulation appears to act by one or more of the following mechanisms: (1) potentiation or enhance-
ment of excitatory neurotransmission, (2) depression or antagonism of inhibitory neurotransmission, and (3)
altered presynaptic control of neurotransmitter release.
Although the use of CNS stimulants (also known as analeptics or convulsants) has declined, certain
compounds within this category do possess some clinical utility. Historically, general CNS stimulants were used primarily as respiratory stimulants in the treatment of acute overdosage with CNS depressants (e.g., barbiturates). Several factors have contributed to the almost complete lack of use of CNS stimulants in this clinical situation. First, since the stimulants were not specific antagonists of the depressant agents, they frequently were not effective in reversing severe pharmacologically induced CNS depression. Second, the duration of action of the CNS stimulant was generally shorter than that of the depressant. Third, the dose of most CNS stimulants required to reverse severe CNS depression was quite close to the dose that produced convulsions and cardiac arrhythmias. In such cases, the CNS stimulant often exacerbated the clinical picture by producing severe lifethreatening complications. Another factor contributing to the decline in CNS stimulant use for drug-induced CNS depression has been the development of generally
safer procedures for patient management. Supportive measures (e.g., maintenance of a patent airway, eleva-
tion of low blood pressure) often provide greater benefit to the patient than does the use of analeptic drugs.
Tolerance and abuse potential are additional problems associated with the use of such psychomotor stimulants
as amphetamine and many of its congeners.
Compounds that possess as their primary action the stimulation of the CNS can be divided into three major
categories based on either their proposed mechanism of action or their chemical structure. Each
class of compounds is discussed in general terms, and individual drugs are mentioned only as appropriate.
Anda baru saja membaca artikel yang berkategori Nervous System Stimulants
dengan judul Central Nervous System Stimulants. Anda bisa bookmark halaman ini dengan URL https://medipub.blogspot.com/2010/12/central-nervous-system-stimulants_21.html. Terima kasih!
Ditulis oleh:
Unknown - Tuesday 21 December 2010
